Gainers
- Applied Molecular AMTI shares increased by 19.38% to $35.54 during Friday's pre-market session. The market value of their outstanding shares is at $1.3 billion.
- Athersys ATHX stock rose 16.23% to $1.79. The market value of their outstanding shares is at $404.9 million.
- Intersect ENT XENT stock moved upwards by 13.17% to $27.75. The company's market cap stands at $919.6 million. The company's, Q2 earnings came out today.
- Sensus Healthcare SRTS shares rose 12.14% to $3.97. The market value of their outstanding shares is at $65.4 million. The company's, Q2 earnings came out yesterday.
- Gemini Therapeutics GMTX stock increased by 11.16% to $4.48. The market value of their outstanding shares is at $192.8 million.
- Graphite Bio GRPH shares rose 9.87% to $22.69. The market value of their outstanding shares is at $1.3 billion.
Losers
- Spectrum Pharmaceuticals SPPI shares fell 35.08% to $2.11 during Friday's pre-market session. The company's market cap stands at $346.2 million.
- Dicerna Pharmaceuticals DRNA stock fell 28.93% to $26.95. The market value of their outstanding shares is at $2.0 billion.
- Collegium Pharmaceutical COLL stock fell 14.66% to $21.2. The market value of their outstanding shares is at $747.2 million. The company's, Q2 earnings came out yesterday.
- Chembio Diagnostics CEMI shares declined by 13.64% to $3.04. The market value of their outstanding shares is at $61.7 million. As per the news, the Q2 earnings report came out yesterday.
- icad ICAD shares declined by 12.99% to $13.4. The company's market cap stands at $334.5 million. As per the press release, Q2 earnings came out yesterday.
- Novavax NVAX stock fell 11.1% to $210.0. The market value of their outstanding shares is at $15.5 billion. As per the press release, Q2 earnings came out yesterday.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in